# üî¨ Interferon gamma-1b Path Analysis Report

*Generated: 2025-12-07 14:00:25*

## 1. Drug Profile

| Property | Value |
|----------|-------|
| **Drug ID** | DB00033 |
| **Drug Name** | Interferon gamma-1b |
| **Type** | drug |

## 2. Path Statistics

| Metric | Value |
|--------|-------|
| **Total Paths** | 100 |
| **Unique Diseases** | 78 |
| **Mean Attention** | 0.6200 |
| **Std Attention** | 0.0790 |
| **Min Attention** | 0.4556 |
| **Max Attention** | 0.7697 |

### Paths by Hop Count

| Hops | Count |
|------|-------|
| 2 | 400 |
| 3 | 400 |
| 4 | 400 |
| 5 | 400 |

## 3. Path Type Summary

| Path Type | Count | Description |
|-----------|-------|-------------|
| Drug Similarity | 100 | Paths through similar drugs |
| Protein Target | 0 | Paths through protein targets |
| Pathway | 0 | Paths through biological pathways |
| Biological Process | 0 | Paths through biological processes |
| Other | 0 | Other connection types |

### Key Similar Drugs

| Similar Drug | Max Attention | # Diseases |
|--------------|---------------|------------|
| Estradiol valerate | 0.8267 | 35 |
| Urokinase | 0.8064 | 1 |
| Quinine | 0.8023 | 18 |
| Rivaroxaban | 0.7986 | 6 |
| Dasatinib | 0.7939 | 8 |
| Ethinylestradiol | 0.7913 | 18 |
| Conjugated estrogens | 0.7884 | 1 |
| Dabigatran etexilate | 0.7851 | 1 |
| Ibrutinib | 0.7737 | 2 |
| Tamoxifen | 0.7619 | 10 |

## 4. Top 20 Paths (by Combined Score)

### Path #1: phosphorus metabolism disease

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.570)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6986 |
| Combined Score | 0.4939 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with phosphorus metabolism disease. This suggests shared therapeutic mechanisms.

---

### Path #2: neurotic disorder

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.567)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6968 |
| Combined Score | 0.4927 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with neurotic disorder. This suggests shared therapeutic mechanisms.

---

### Path #3: hypertrophy of breast

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.562)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6946 |
| Combined Score | 0.4912 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with hypertrophy of breast. This suggests shared therapeutic mechanisms.

---

### Path #4: uterine corpus leiomyoma

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.562)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6945 |
| Combined Score | 0.4911 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with uterine corpus leiomyoma. This suggests shared therapeutic mechanisms.

---

### Path #5: hypothyroidism

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.562)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6942 |
| Combined Score | 0.4908 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with hypothyroidism. This suggests shared therapeutic mechanisms.

---

### Path #6: intrinsic asthma

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.558)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6922 |
| Combined Score | 0.4894 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with intrinsic asthma. This suggests shared therapeutic mechanisms.

---

### Path #7: myxedema

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.551)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6889 |
| Combined Score | 0.4872 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with myxedema. This suggests shared therapeutic mechanisms.

---

### Path #8: dysthymic disorder

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.550)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6882 |
| Combined Score | 0.4866 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with dysthymic disorder. This suggests shared therapeutic mechanisms.

---

### Path #9: hypertriglyceridemia (disease)

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.549)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6880 |
| Combined Score | 0.4865 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with hypertriglyceridemia (disease). This suggests shared therapeutic mechanisms.

---

### Path #10: congestive heart failure

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.549)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6878 |
| Combined Score | 0.4863 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with congestive heart failure. This suggests shared therapeutic mechanisms.

---

### Path #11: humoral hypercalcemia of malignancy

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.548)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6875 |
| Combined Score | 0.4861 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with humoral hypercalcemia of malignancy. This suggests shared therapeutic mechanisms.

---

### Path #12: pyoureter

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.544)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6855 |
| Combined Score | 0.4847 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with pyoureter. This suggests shared therapeutic mechanisms.

---

### Path #13: gallbladder disease

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.544)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6854 |
| Combined Score | 0.4846 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with gallbladder disease. This suggests shared therapeutic mechanisms.

---

### Path #14: allergic asthma

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.541)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6840 |
| Combined Score | 0.4836 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with allergic asthma. This suggests shared therapeutic mechanisms.

---

### Path #15: hypertension

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.541)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6838 |
| Combined Score | 0.4835 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with hypertension. This suggests shared therapeutic mechanisms.

---

### Path #16: inherited porphyria

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6823 |
| Combined Score | 0.4824 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with inherited porphyria. This suggests shared therapeutic mechanisms.

---

### Path #17: systemic lupus erythematosus (disease)

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6822 |
| Combined Score | 0.4824 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with systemic lupus erythematosus (disease). This suggests shared therapeutic mechanisms.

---

### Path #18: anxiety disorder

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.537)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6821 |
| Combined Score | 0.4823 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with anxiety disorder. This suggests shared therapeutic mechanisms.

---

### Path #19: hypercalcemia disease

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.537)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6821 |
| Combined Score | 0.4823 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with hypercalcemia disease. This suggests shared therapeutic mechanisms.

---

### Path #20: porphyrin metabolism disease

**Path:**
```
[Interferon gamma-1b] --(0.827)--> [Estradiol valerate] --(0.536)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6813 |
| Combined Score | 0.4817 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Interferon gamma-1b is similar to Estradiol valerate, which is associated with porphyrin metabolism disease. This suggests shared therapeutic mechanisms.

---

## 5. Interpretation Guidelines

### Attention Score Scale

| Score Range | Confidence | Interpretation |
|-------------|------------|----------------|
| ‚â• 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High | Strong biological relationship |
| 0.60 - 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê High | Good evidence for connection |
| 0.50 - 0.60 | ‚≠ê‚≠ê‚≠ê Medium | Moderate support |
| 0.40 - 0.50 | ‚≠ê‚≠ê Low | Weak connection |
| < 0.40 | ‚≠ê Very Low | Speculative |

### How to Use This Report

1. **Prioritize high-scoring paths**: Focus on paths with combined scores > 0.45
2. **Validate intermediate nodes**: Cross-reference proteins/drugs with literature
3. **Consider path length**: Shorter paths (2-3 hops) are generally more reliable
4. **Check for known associations**: Some paths may represent known indications

---

*Report generated by TxGNN Path Analysis Pipeline*